SC 13D

Company

AIM ImmunoTech Inc.

Filed

July 27, 2023

Accession Number

0001193125-23-196184

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →